January 05, 2016  



What made the news 2015

Scientific Editor Jane Stock looks back at 2015 and on what made the news during the year in the field of atherosclerosis. Her commentary reports on an eventful year for atherosclerosis activities and discusses highlights - including Familial hypercholesterolemia (FH), new treatments targeted towards Lp(a), developments targeting ApoCIII and PCSK9 - but also not so good news...

Read more What made the news 2015 >>


Think Again About Cholesterol - survey results published

Our Think Again About Cholesterol survey results have been published as a supplement in Atherosclerosis. The survey was originally launched this September in support of World Heart Day and FH Awareness Day to raise awareness of the public’s understanding of cholesterol. The survey found there is a discrepancy between understanding the importance of high cholesterol and taking action against the risk for cardiovascular disease. In fact, although 89 percent of adults surveyed agreed it is important to know whether or not they have high low-density lipoprotein cholesterol (LDL-C), 92 percent did not know their cholesterol levels or never had their cholesterol levels tested.

More information and detailed survey results >>


Your input needed to improve the next research and innovation framework programme of the European Union

The European Commission is planning the interim evaluation of Horizon 2020 which will be crucial to the future of biomedical research funding in Europe. Under the umbrella of the Alliance for Biomedical Research in Europe (BioMed Alliance), representing 21 leading European biomedical societies that together include more than 400,000 researchers and health professionals across Europe, a dedicated Task Force has been appointed with the role of monitoring the framework programme Horizon 2020. If you have had any experience with Horizon 2020, you are kindly asked to answer a short survey giving your experiences and opinion of with the programme before 10 January 2016. The survey should take approximately 10 minutes of your time.

More info about the BioMed Alliance and evaluation of Horizon 2020 >>

Directly to the survey - deadline January 10 >>


We welcome to EAS 2016 Innsbruck Professor Rudolf Zechner, Austria. Professor Zechner will present a Plenary lecture on the topic "Pathophysiology of intracellular and intravascular lipolysis ".

More about Professor Zechner >>


We welcome also Professor Jörg Heeren, Germany. Professor Heeren will present a Plenary lecture on the topic "Adipose tissue browning and metabolic health".

More about Professor Heeren >>

More about the Congress Programme >>


Find out more

About this email


European Atherosclerosis Society © 2015

This email was sent to '@@email@@' from European Atherosclerosis Society.
If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@